Identify the PIK3CA mutations that matter
Oncology | Breast Cancer

Identify the PIK3CA mutations that matter

Empower your oncologists with results they can trust

Global Solid Tumor Summit

Global Solid Tumor Summit

On April 25 and 26, hear how advances in technology, such as dPCR and NGS are driving improvements in biomarker testing in solid tumors.

Register now
Contact an expert
Discover how QIAGEN can help you and your patients.
Get in touch
Find a lab that offers PIK3CA testing
Explore our lab finder portal to find labs in your region offering PIK3CA and other IVD biomarker tests.
Find a lab
Solid tumor webinar hub

Solid tumor webinar hub

Catch up with our solid tumor webinars on demand, wherever you are, at a time that works for you.

Go to hub
The hallmark of cancer
The hallmark of cancer
Want to be the first to learn about our new homologous recombination deficiency (HRD) panel? Our HRD panel can help you confidently analyze mutations in the DNA damage repair genes.
DNA repair status is relevant
DNA repair status is relevant
Learn how our homologous recombination repair (HRR) panel will expand your biomarker coverage beyond BRCA1/2.
Read more
Interested in comprehensive tumor profiling?
Interested in comprehensive tumor profiling?
The QIAseq Pan-cancer Multimodal Panel allows simultaneous profiling of DNA variants and RNA fusions
Discover more